ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

ClinicalTrials.gov ID: NCT00316212

Public ClinicalTrials.gov record NCT00316212. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass

Study identification

NCT ID
NCT00316212
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • INS50589 Intravenous Infusion Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Jul 31, 2006
Completion
Not listed
Last update posted
Nov 17, 2016

Started 2006

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Baptist Medical Center Princeton Birmingham Alabama 35211
Cardiology, P.C. Birmingham Alabama 35211
Sharp Memorial Hospital San Diego California 92123
Memorial Medical Center Springfield Illinois 62702
St. John's Hospital Springfield Illinois 62769
Southern Illinois University School of Medicine Springfield Illinois 62794-9638
Lutheran Hospital of Indiana Fort Wayne Indiana 46804
Veterans Affairs Medical Center Lexington Kentucky 40506
University of Kentucky, Chandler Medical Center Lexington Kentucky 40536
St. Mary's of Michigan Saginaw Michigan 48601
Covenant Medical Center Saginaw Michigan 48602
Viahealth Rochester General Hospital Rochester New York 14621
Duke University Medical Center Durham North Carolina 27710
The Brody School of Medicine, East Carolina University Greenville North Carolina 27834
Cardiac, Vascular, & Thoracic Surgeons, Inc. Cincinnati Ohio 45209
Good Samaritan Hospital Cincinnati Ohio 45220
Bethesda North Hospital Cincinnati Ohio 45242
Oklahoma Cardiovascular Associates Oklahoma City Oklahoma 73120
Oklahoma Cardiovascular Research Group Oklahoma City Oklahoma 73120
Oklahoma Heart Hospital Oklahoma City Oklahoma 73120
CardioThoracic Surgery Center, PLC Jackson Tennessee 38301
Jackson Madison County General Hospital Jackson Tennessee 38301
Centennial Medical Center Nashville Tennessee 37203
The Methodist Hospital Houston Texas 77030
Winchester Medical Center Winchester Virginia 22601
FHS Research Center, St. Joseph Medical Center Tacoma Washington 98405
Northwest Cardiovascular Associates Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00316212, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2016 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00316212 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →